The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Precision oncology: the UC San Diego Moores Cancer Center PREDICT experience.
 
Barbara A. Parker
Stock and Other Ownership Interests - Merck (I)
Research Funding - GlaxoSmithKline (Inst)
 
Maria Clemence Schwaederle
No Relationships to Disclose
 
Richard B. Schwab
Stock and Other Ownership Interests - Samumed (I)
Patents, Royalties, Other Intellectual Property - The patent covers sialylated glycans and antibodies that specifically bind to them for early detection and diagnosis of cancer. (Inst)
 
Gregory A. Daniels
No Relationships to Disclose
 
David Eric Piccioni
No Relationships to Disclose
 
Teresa L. Helsten
Research Funding - Abbvie (Inst); Bayer (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech (Inst); Lilly (Inst); Merrimack (Inst); Novartis (Inst); Pfizer (Inst); Roche Pharma AG (Inst)
 
Lyudmila Bazhenova
Stock and Other Ownership Interests - Epic Sciences
Honoraria - Novartis
Consulting or Advisory Role - Boehringer Ingelheim; Clovis Oncology; Seagen
Speakers' Bureau - Genentech; Pfizer
Research Funding - ARIAD (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Eisai (Inst); Heat Biologics (Inst); Johnson & Johnson (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Mirati Therapeutics (Inst); NanoCarrier (Inst); Novartis (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Clovis Oncology; Genentech; Pfizer; Seagen
 
Paul T. Fanta
No Relationships to Disclose
 
Scott Michael Lippman
No Relationships to Disclose
 
Razelle Kurzrock
Stock and Other Ownership Interests - RScueRx
Honoraria - AACR; ASCO; Cancer Treament Centers of America; Cedars-Sinai; Clearview Healthcare Partners; CTRC-EAB San Antonio; Frankel Group; Janssen; Jubilant Biosys; Lynx Group; Merck; NCCN; SAIC NCI CCCT Investigational Drug Steering Committee; Segal Cancer Center; The Dedham Group; University of Arizona; Usha Mahajani Foundation
Consulting or Advisory Role - AACR; CTRC-EAB San Antonio; Janssen; Jubilant Biosys; Merck; SAIC NCI CCCT IDSE
Research Funding - Centocor Ortho Biotech; EMD Serono; EMD Serono; EMD Serono; Exelixis; GlaxoSmithKline; GlaxoSmithKline; Merck; Merck; Novartis; Roche/Genentech; XBiotech
Patents, Royalties, Other Intellectual Property - Patent; Patent; Patent; Patent
Travel, Accommodations, Expenses - Cancer Treament Centers of America; EMD Serono; Gateway Research Advisory Committee; Gateway Research Advisory Committee; Global Biomarkers Consortium; ICRP; WIN Pharma; WIN Pharma